Prevalence of hepatitis E virus antibodies, Israel, 2009-2010

Emerg Infect Dis. 2015 Apr;21(4):692-4. doi: 10.3201/eid2104.140245.

Abstract

We investigated prevalence of hepatitis E virus in a sample of the population of Israel. The overall seroprevalence of antibodies to the virus was 10.6% (95% CI 8.4%-13.0%); age-adjusted prevalence was 7.6%. Seropositivity was associated with age, Arab ethnicity, low socioeconomic status, and birth in Africa, Asia, or the former Soviet Union.

Keywords: Anti-HEV; HEV; IgG; Israel; antibodies; hepatitis E; hepatitis E virus; prevalence; seroprevalence; viruses.

Publication types

  • Historical Article

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Genotype
  • Hepatitis Antibodies / immunology*
  • Hepatitis E / epidemiology*
  • Hepatitis E / history
  • Hepatitis E / immunology*
  • Hepatitis E / transmission
  • Hepatitis E virus / genetics
  • Hepatitis E virus / immunology*
  • History, 21st Century
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Immunoglobulin M / blood
  • Immunoglobulin M / immunology
  • Israel / epidemiology
  • Male
  • Middle Aged
  • Odds Ratio
  • Prevalence
  • Seroepidemiologic Studies
  • Young Adult

Substances

  • Hepatitis Antibodies
  • Immunoglobulin G
  • Immunoglobulin M